The prognostic value of IgG OCB in predicting clinical outcomes in CIS is well established , and emerging data suggest that FLCs may have similar prognostic relevance . Villar et al.  investigated whether κ FLC CSF concentrations in patients with CIS were predictive of conversion to MS. The study included 78 consecutive CIS patients and 25 controls (patients with non-inflammatory neurological diseases). A cut-off value of κ FLC CSF >0.53 mg/L (defined as the mean + 2 standard deviations for the control group) identified CIS patients with an increased probability of conversion to MS (p<0.0001). In a multivariate Cox regression analysis (adjusted for gender, age and basal MRI findings), the hazard ratio was 6.41 (p<0.003)., using a cut-off of >0.38 mg/L to identify patients at increased risk of MS (p<0.0001). The same research group subsequently reported the predictive value of the κ FLC index to identify CIS patients at highest risk of conversion to MS, using a cut-off of 10.62 (defined by ROC analysis) . CIS patients with a κ FLC index >10.62 had a 7.3-fold higher risk of progression compared with those with an index below this value (Figure 36.5, p<0.0001). On multivariate Cox regression analysis (that also included the patient’s age, sex, and the dissemination of lesions in space by MRI), the κ FLC index remained prognostic for conversion to MS.
Conversely, Presslauer et al.  did not find a significant difference in the κ FLC index values between stable CIS patients and those who underwent conversion to MS, but the number of patients was small (n=24). Therefore, the prognostic value of FLC CSF measurements warrants further investigation.